Opening subject page...
Loading your content
From monosaccharide stereochemistry to the metabolic pathways that extract and store biological energy.
The study of carbohydrates stretches back to the earliest days of organic chemistry, when scientists recognized that certain plant-derived substances shared the empirical formula Cn(H2O)n, literally 'hydrates of carbon.' This seemingly simple formula conceals extraordinary structural diversity: the ability of aldehyde and ketone functional groups to combine with multiple chiral centers generates an immense family of stereoisomers, each with distinct biological roles. Understanding the interplay between carbohydrate structure and metabolic function has been a central preoccupation of biochemistry for over two centuries, yielding Nobel Prizes and transforming our comprehension of cellular energetics, signal transduction, and molecular recognition.
The MCAT examines carbohydrate biochemistry at the intersection of organic chemistry and physiology: you must understand how stereochemistry dictates biological activity, how glycolysis and gluconeogenesis are regulated reciprocally, and how metabolic flux responds to hormonal signals. This lesson provides a unified treatment of carbohydrate structure, classification, ring formation, glycosidic bonding, and the principal catabolic and anabolic pathways—glycolysis, the pentose phosphate pathway, glycogenesis, and glycogenolysis.
Carbohydrates are polyhydroxylated aldehydes or ketones (or compounds that yield them upon hydrolysis). Their structural complexity arises from multiple chiral centers, ring–chain tautomerism, and the capacity to form glycosidic bonds that link monomers into oligosaccharides and polysaccharides. The following foundational concepts underpin every MCAT question in this domain.
The diagram above illustrates how the linear aldehyde form of D-glucose undergoes intramolecular cyclization. The C-5 hydroxyl group acts as the nucleophile, attacking the electrophilic C-1 carbonyl carbon to form a six-membered pyranose ring. This reaction creates a new stereocenter—the anomeric carbon—yielding two diastereomers: the α anomer (anomeric OH on the same side as the ring oxygen in a Haworth projection, or axial in a chair conformation) and the β anomer (anomeric OH on the opposite side, or equatorial). In aqueous solution, both anomers interconvert through the open-chain intermediate, a process called mutarotation, reaching an equilibrium ratio of approximately 36:64 (α:β) for D-glucose at 25 °C. The β anomer predominates because the equatorial orientation of the bulky hydroxyl group at C-1 minimizes 1,3-diaxial interactions.
Carbohydrate metabolism begins with glycolysis, a ten-step cytosolic pathway that converts one molecule of glucose (C6H12O6) into two molecules of pyruvate (CH3COCOO−). The pathway is divided into an energy-investment phase (steps 1–5, consuming 2 ATP) and an energy-payoff phase (steps 6–10, producing 4 ATP and 2 NADH). The net yield per glucose molecule is therefore 2 ATP + 2 NADH + 2 pyruvate.
Three irreversible steps govern flux through glycolysis. Hexokinase (step 1) phosphorylates glucose to glucose-6-phosphate, trapping it in the cell; it is inhibited by its product, glucose-6-phosphate. Phosphofructokinase-1 (PFK-1) (step 3) catalyzes the committed step—phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate—and is the primary regulatory point of the pathway. PFK-1 is allosterically activated by AMP, ADP, and fructose-2,6-bisphosphate, and inhibited by ATP, citrate, and H+. Pyruvate kinase (step 10) converts phosphoenolpyruvate to pyruvate with concomitant ATP generation; it is activated by fructose-1,6-bisphosphate (feedforward activation) and inhibited by ATP and alanine.
The metabolic fate of pyruvate depends on oxygen availability and tissue type. Under aerobic conditions, pyruvate enters the mitochondrial matrix, where the pyruvate dehydrogenase complex (PDC) catalyzes oxidative decarboxylation to acetyl-CoA + CO2 + NADH. Acetyl-CoA then enters the citric acid cycle. Under anaerobic conditions, lactate dehydrogenase (LDH) reduces pyruvate to lactate, regenerating NAD+ so glycolysis can continue. In yeast and certain microorganisms, alcoholic fermentation decarboxylates pyruvate to acetaldehyde, which is then reduced to ethanol.
Beyond glycolysis, two additional carbohydrate pathways are high-yield MCAT topics: glycogen metabolism (synthesis and degradation of the storage polysaccharide glycogen) and the pentose phosphate pathway (PPP), which generates NADPH and ribose-5-phosphate.
Glycogenesis (glycogen synthesis) begins with glucose-6-phosphate, which is isomerized to glucose-1-phosphate by phosphoglucomutase, then activated to UDP-glucose by UDP-glucose pyrophosphorylase. Glycogen synthase transfers glucose residues to the non-reducing end of the growing chain via α-1,4 linkages, while branching enzyme creates α-1,6 branch points approximately every 8–12 residues. Glycogenolysis reverses this process: glycogen phosphorylase cleaves α-1,4 bonds by phosphorolysis (not hydrolysis), releasing glucose-1-phosphate directly. A debranching enzyme handles α-1,6 linkages. Regulation is achieved through reciprocal phosphorylation cascades: epinephrine and glucagon promote glycogenolysis (via phosphorylase kinase), while insulin activates glycogenesis (via protein phosphatase-1).
The PPP branches from glycolysis at glucose-6-phosphate and operates in two phases. The oxidative phase is irreversible: glucose-6-phosphate dehydrogenase (G6PD)—the rate-limiting enzyme—oxidizes G6P while reducing NADP+ to NADPH. After two further reactions, ribulose-5-phosphate and CO2 are produced. The non-oxidative phase reversibly interconverts sugar phosphates of varying chain lengths (C3–C7) through the actions of transketolase and transaldolase, ultimately recycling carbon skeletons back to glycolytic intermediates. NADPH from the PPP is essential for reductive biosyntheses (fatty acid synthesis, cholesterol synthesis) and for maintaining glutathione in its reduced state, which protects erythrocytes against oxidative damage—hence the clinical significance of G6PD deficiency.
A common MCAT question asks you to calculate the total ATP yield from the complete oxidation of one molecule of glucose under aerobic conditions. This requires integrating glycolysis, the pyruvate dehydrogenase reaction, the citric acid cycle, and oxidative phosphorylation.
Carbohydrate metabolism is exquisitely regulated by hormonal signals—primarily insulin, glucagon, and epinephrine—that coordinate the fed-state and fasted-state metabolic programs. The following table contrasts key opposing pathways and their regulatory logic.
| Feature | Glycolysis / Glycogenesis | Gluconeogenesis / Glycogenolysis |
|---|---|---|
| Primary signal | Insulin (fed state) | Glucagon (fasted), Epinephrine (stress) |
| Key tissue | Liver, muscle, adipose | Liver (gluconeogenesis), liver + muscle (glycogenolysis) |
| Rate-limiting enzyme | PFK-1 (glycolysis); Glycogen synthase (glycogenesis) | Fructose-1,6-bisphosphatase (GNG); Glycogen phosphorylase (glycogenolysis) |
| Allosteric activators | AMP, fructose-2,6-bisphosphate (PFK-1); G6P (glycogen synthase) | ATP, citrate (F-1,6-BPase); AMP, Ca²⁺ (phosphorylase) |
| Mechanism of hormonal control | Insulin → protein phosphatase-1 → dephosphorylation activates glycogen synthase and PFK-2 | Glucagon/epi → cAMP → PKA → phosphorylation activates phosphorylase kinase, inactivates glycogen synthase |
| Energy state favoring | Low energy charge (↑AMP, ↓ATP) | High energy charge (↑ATP, ↑citrate) |
The MCAT frequently connects metabolic biochemistry to clinical scenarios. Several diseases arise directly from defects in carbohydrate metabolism, and understanding them reinforces pathway logic.
| Condition | Defective Enzyme / Pathway | Metabolic Consequence |
|---|---|---|
| G6PD Deficiency | Glucose-6-phosphate dehydrogenase (PPP oxidative phase) | ↓ NADPH → ↓ reduced glutathione → hemolytic anemia upon oxidative stress (e.g., fava beans, sulfonamides) |
| Von Gierke Disease (GSD I) | Glucose-6-phosphatase (final step releasing free glucose from liver) | Severe fasting hypoglycemia, hepatomegaly, lactic acidosis, hyperlipidemia |
| McArdle Disease (GSD V) | Muscle glycogen phosphorylase | Exercise intolerance, myoglobinuria; liver glycogenolysis intact so no fasting hypoglycemia |
| Galactosemia | Galactose-1-phosphate uridylyltransferase (galactose metabolism) | Accumulation of galactose-1-phosphate → cataracts, intellectual disability, hepatomegaly in neonates fed lactose |
| Pyruvate Kinase Deficiency | Pyruvate kinase (glycolysis step 10) | ↓ ATP in RBCs → chronic hemolytic anemia; no mitochondria in RBCs so glycolysis is sole ATP source |
Beyond these monogenic disorders, the interplay between carbohydrate metabolism and broader physiology connects to advanced topics examined on the MCAT. The Warburg effect describes cancer cells' preference for aerobic glycolysis (high glycolytic rate with lactate production even in the presence of oxygen), which supports rapid proliferation by providing biosynthetic intermediates. The Cori cycle shuttles lactate from muscle to liver, where gluconeogenesis regenerates glucose—an inter-organ metabolic partnership. Understanding these connections demonstrates mastery of the integrated metabolic logic the MCAT rewards.
Carbohydrates are classified as aldoses or ketoses based on their carbonyl group and by chain length (triose through hexose). Their multiple chiral centers generate rich stereochemical diversity; the D/L designation refers to the configuration of the highest-numbered chiral center, and epimers differ at a single stereocenter. Cyclization creates a hemiacetal or hemiketal ring and a new anomeric carbon (α vs. β), with interconversion occurring through mutarotation. Glycosidic bonds (α-1,4; β-1,4; α-1,6) determine polysaccharide digestibility and biological function.
Metabolically, glucose-6-phosphate is the critical branch point feeding into glycolysis (net 2 ATP + 2 NADH → pyruvate), the pentose phosphate pathway (NADPH + ribose-5-P), and glycogenesis. Complete aerobic oxidation of glucose yields approximately 30–32 ATP. Pathway regulation is reciprocal: insulin promotes anabolism (glycogenesis, glycolysis via PFK-2 activation), while glucagon and epinephrine promote catabolism (glycogenolysis, gluconeogenesis) through cAMP-dependent phosphorylation cascades. Clinical correlations—G6PD deficiency, glycogen storage diseases, galactosemia—illustrate how single enzyme defects produce predictable metabolic consequences, a reasoning pattern central to the MCAT.